Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolactin added to embryo transfer media in frozen embryo transfer cycles
IRCT20260921071136N1Phase 3Not yet recruiting
- Sponsor
- Semnan University of Medical Sciences
- Start
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of recombinant human prolactin and hyaluronic acid in infertility (3 arms), sponsored by Semnan University of Medical Sciences. Primary endpoint: Live birth rate. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
recombinant human prolactinhyaluronic acid
03
Conditions
infertility
Beyond the preview
Go deeper on IRCT20260921071136N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260921071136N1.